NM_001369.3:c.9721-12A>T

Variant names:

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001369.3(DNAH5):c.9721-12A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.356 in 1,612,898 control chromosomes in the GnomAD database, including 103,426 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 9292 hom., cov: 33)

Exomes 𝑓: 0.36 ( 94134 hom. )

Consequence

DNAH5
NM_001369.3 intron

Scores

Splicing: ADA: 0.00001179

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -2.82

Publications

8 publications found

Variant links:

Genes affected

DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]

DNAH5 Gene-Disease associations (from GenCC):

primary ciliary dyskinesia 3
Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
primary ciliary dyskinesia
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

DNAH5 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.9).

BP6

Variant 5-13769148-T-A is Benign according to our data. Variant chr5-13769148-T-A is described in ClinVar as Benign. ClinVar VariationId is 167003.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BA1

GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.363 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
DNAH5	NM_001369.3 link	c.9721-12A>T		intron_variant	Intron 57 of 78	ENST00000265104.5	NP_001360.1	Q8TE73

Ensembl

Gene	Transcript	HGVSc	Effect	Exon rank	TSL	MANE	Protein	UniProt
DNAH5	ENST00000265104.5 link	c.9721-12A>T	intron_variant	Intron 57 of 78	1	NM_001369.3	ENSP00000265104.4	Q8TE73
DNAH5	ENST00000681290.1 link	c.9676-12A>T	intron_variant	Intron 57 of 78			ENSP00000505288.1	A0A7P0Z455
DNAH5	ENST00000504001.3 link	n.433-12A>T	intron_variant	Intron 3 of 4	5

Frequencies

GnomAD3 genomes

AF:

0.349

AC:

52965

AN:

151936

Hom.:

9288

Cov.:

show subpopulations

Gnomad AFR

AF:

0.332

Gnomad AMI

AF:

0.461

Gnomad AMR

AF:

0.356

Gnomad ASJ

AF:

0.361

Gnomad EAS

AF:

0.331

Gnomad SAS

AF:

0.241

Gnomad FIN

AF:

0.326

Gnomad MID

AF:

0.386

Gnomad NFE

AF:

0.367

Gnomad OTH

AF:

0.362

GnomAD2 exomes

AF:

0.339

AC:

85137

AN:

250844

AF XY:

0.338

show subpopulations

Gnomad AFR exome

AF:

0.330

Gnomad AMR exome

AF:

0.328

Gnomad ASJ exome

AF:

0.375

Gnomad EAS exome

AF:

0.322

Gnomad FIN exome

AF:

0.336

Gnomad NFE exome

AF:

0.368

Gnomad OTH exome

AF:

0.372

GnomAD4 exome

AF:

0.357

AC:

520957

AN:

1460844

Hom.:

94134

Cov.:

AF XY:

0.353

AC XY:

256535

AN XY:

726840

show subpopulations

African (AFR)

AF:

0.339

AC:

11348

AN:

33464

American (AMR)

AF:

0.333

AC:

14891

AN:

44714

Ashkenazi Jewish (ASJ)

AF:

0.372

AC:

9714

AN:

26130

East Asian (EAS)

AF:

0.323

AC:

12813

AN:

39696

South Asian (SAS)

AF:

0.246

AC:

21182

AN:

86240

European-Finnish (FIN)

AF:

0.338

AC:

17975

AN:

53234

Middle Eastern (MID)

AF:

0.413

AC:

2380

AN:

5762

European-Non Finnish (NFE)

AF:

0.368

AC:

408699

AN:

1111246

Other (OTH)

AF:

0.364

AC:

21955

AN:

60358

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.484

Heterozygous variant carriers

17491

34982

52473

69964

87455

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

12864

25728

38592

51456

64320

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.348

AC:

52985

AN:

152054

Hom.:

9292

Cov.:

AF XY:

0.347

AC XY:

25745

AN XY:

74300

show subpopulations

African (AFR)

AF:

0.332

AC:

13787

AN:

41498

American (AMR)

AF:

0.356

AC:

5424

AN:

15256

Ashkenazi Jewish (ASJ)

AF:

0.361

AC:

1255

AN:

3472

East Asian (EAS)

AF:

0.332

AC:

1713

AN:

5166

South Asian (SAS)

AF:

0.238

AC:

1150

AN:

4824

European-Finnish (FIN)

AF:

0.326

AC:

3441

AN:

10542

Middle Eastern (MID)

AF:

0.381

AC:

112

AN:

294

European-Non Finnish (NFE)

AF:

0.367

AC:

24924

AN:

67984

Other (OTH)

AF:

0.360

AC:

759

AN:

2106

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.504

Heterozygous variant carriers

1803

3607

5410

7214

9017

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

532

1064

1596

2128

2660

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.276

Hom.:

1023

Bravo

AF:

0.354

Asia WGS

AF:

0.292

AC:

1015

AN:

3478

ClinVar

Significance: Benign

Submissions summary: Benign:11

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:5

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Feb 21, 2013

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

9721-12A>T in intron 57 of DNAH5: This variant is not expected to have clinical significance because it has been identified in 37.8% (3248/8600) of European Ame rican chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs12655133). -

Feb 18, 2014

Eurofins Ntd Llc (ga)

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

PreventionGenetics, part of Exact Sciences

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Primary ciliary dyskinesia 3

Benign:3

Jun 15, 2021

Pars Genome Lab

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Jan 12, 2018

Illumina Laboratory Services, Illumina

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021

Genome-Nilou Lab

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Benign:2

Nov 10, 2018

GeneDx

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Breakthrough Genomics, Breakthrough Genomics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:not provided

- -

Primary ciliary dyskinesia

Benign:1

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.90

CADD

Benign

0.056

(source)

DANN

Benign

0.25

PhyloP100

-2.8

Mutation Taster

=100/0

polymorphism (auto)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

dbscSNV1_ADA

Benign

0.000012

dbscSNV1_RF

Benign

0.044

SpliceAI score (max)

0.030

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over